Ambiq (AMBQ) Q4 2025 earnings review
Strategic Pivot Succeeds, But Profitability Remains Elusive
Ambiq's painful but necessary strategic pivot away from low-margin Chinese volume is officially paying off. After three quarters of YoY declines, Q4 revenue crossed back into positive territory (+2.0% YoY), hitting a company-record $20.7M. More importantly, the quality of this revenue has structurally transformed: non-GAAP gross margins surged from 26.4% a year ago to 45.5%. However, the cost of developing the next generation of Edge AI (specifically the Atomiq NPU SoC) is steep. Non-GAAP OpEx jumped 26% YoY, outpacing gross profit gains and keeping the company deeply in the red. The growth trajectory is Reversing upward, but the bottom line requires patience.
🐂 Bull Case
The company has posted sequential net sales growth in every single quarter of 2025. Q1 2026 guidance implies roughly 37% YoY revenue growth, confirming the top-line slump is over.
By walking away from commoditized Chinese volume, Ambiq nearly doubled its gross margins year-over-year. The new ~45% baseline appears stable and allows higher-value edge AI deployments to drop significantly more cash to the gross profit line.
🐻 Bear Case
Non-GAAP OpEx hit $16.6M in Q4 (up 26.8% YoY). With Q1 2026 OpEx guided even higher to $18.0-$18.5M, operating leverage is moving in the wrong direction despite the impressive gross margin expansion.
The company consumed $19.7M in operating cash flow during FY25. While the recent IPO provides a massive $140M cash cushion, the core business model is not yet self-sustaining.
⚖️ Verdict: ⚪
Neutral. The operational execution of the strategic pivot was flawless—revenue is recovering and margins are radically higher. However, the accelerating R&D spend required to compete in the Edge AI silicon space means operating breakeven remains a distant milestone.
Key Themes
Geographic Diversification Drives Structural Margin Expansion
The decision to aggressively de-emphasize Mainland China revenue (which dropped from 42% in Q2 2024 to 11.5% by mid-2025) has permanently elevated the financial profile. Non-GAAP gross profit jumped 75.5% YoY in Q4 on just 2.0% higher revenue. This Stable, higher-quality revenue mix is the primary engine for Ambiq's unit economics.
Next-Gen Silicon Rollout: Atomiq & Apollo
Product momentum is Accelerating. Ambiq unveiled Atomiq, the world's first ultra-low-power NPU SoC operating at an unprecedented 300mV, specifically targeting high-performance vision applications. Combined with the launch of three new Apollo variants (including Apollo510B with integrated BLE), the company is aggressively expanding its Total Addressable Market (TAM) beyond simple wearables.
Industrial Edge Expansion
The newly announced partnership with RONDS to deploy always-on, battery-powered AI sensors for heavy industrial applications validates Ambiq's strategy to move beyond consumer electronics. This diversifies end-market exposure and provides sticky, high-margin enterprise recurring revenue potential.
R&D Spend Reversing Operating Leverage
Developing cutting-edge NPU architectures is expensive. Non-GAAP R&D expenses jumped from $6.9M in Q3 to $9.3M in Q4. Because OpEx ($16.6M) grew faster in absolute dollars than Gross Profit ($9.4M) in Q4, the company is actually seeing negative operating leverage in the short term, pushing profitability further out.
Net Losses Remain Stubbornly High
Despite a record year for gross profit, Ambiq posted a full-year GAAP net loss of $36.5M. The Q4 non-GAAP net loss of $5.9M represents an improvement over the prior year ($7.5M), but indicates that substantial volume scaling is still required before the company can cross the breakeven threshold.
Macro Pressures on Hardware Supply Chains
While the company has drastically reduced its dependency on Chinese demand, the semiconductor supply chain remains highly exposed to broader macro instability and tariff uncertainty. Management previously noted Q2 2025 experienced pull-ins due to tariff fears; any further disruption could introduce lumpiness to the newly stabilized revenue trajectory.
Other KPIs
Cash position is Accelerating, up from $61.0M at the end of FY24. This was entirely fueled by the successful IPO and follow-on offering which netted roughly $179.5M combined. This provides a multi-year runway to fund the Atomiq rollout despite the ongoing $20M+ annual operating cash burn.
Stable YoY (compared to negative $21.4M in FY24). While the business model is still cash-consumptive, working capital management was tight, with inventory only increasing modestly to $16.9M despite the preparation for new product launches.
Guidance
Accelerating. The midpoint of $21.5M implies consecutive sequential growth and represents a massive ~37% YoY leap compared to the $15.7M generated in Q1 2025. This confirms the China revenue headwind has fully washed out of the comparable base.
Stable. The guide holds the massive gains achieved in FY25, proving that the shift from 30% to 45% margins was a permanent structural reset driven by product mix, not a temporary anomaly.
Accelerating. Up sequentially from $16.6M in Q4. This surge in spending is heavily tied to the tape-out and commercialization efforts for the new Atomiq NPU architecture.
Stable. Based on ~20.38 million shares outstanding, this implies a total non-GAAP net loss of approximately $7.3 million, widening slightly from the $5.9 million loss in 25Q4 due to the guided step-up in OpEx.
Key Questions
Breakeven Scale
With non-GAAP OpEx stepping up to $18M+ in Q1, what is the new quarterly revenue run-rate required to achieve non-GAAP operating breakeven at a 45% gross margin?
Atomiq Commercialization Timeline
The unveiling of the 12nm Atomiq NPU SoC is a major milestone. When do you expect meaningful volume shipments and revenue contribution to begin hitting the P&L?
Industrial Revenue Contribution
Regarding the RONDS partnership for heavy industrial sensors, how much of the 2026 growth algorithm is predicated on industrial edge deployments versus traditional consumer wearables?